- Home
- ECOR vs SDST Comparison
ECOR vs SDST Comparison
Compare ECOR & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- SDST
- Stock Information
- Founded
- ECOR 2005
- SDST 2022
- Country
- ECOR United States
- SDST United States
- Employees
- ECOR N/A
- SDST N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SDST Blank Checks
- Sector
- ECOR Health Care
- SDST Finance
- Exchange
- ECOR Nasdaq
- SDST Nasdaq
- Market Cap
- ECOR 37.1M
- SDST 34.3M
- IPO Year
- ECOR 2018
- SDST N/A
- Fundamental
- Price
- ECOR $4.96
- SDST $2.93
- Analyst Decision
- ECOR Strong Buy
- SDST Buy
- Analyst Count
- ECOR 2
- SDST 2
- Target Price
- ECOR $25.50
- SDST $1.70
- AVG Volume (30 Days)
- ECOR 99.3K
- SDST 1.2M
- Earning Date
- ECOR 08-06-2025
- SDST 08-13-2025
- Dividend Yield
- ECOR N/A
- SDST N/A
- EPS Growth
- ECOR N/A
- SDST N/A
- EPS
- ECOR N/A
- SDST N/A
- Revenue
- ECOR $27,700,000.00
- SDST N/A
- Revenue This Year
- ECOR $24.48
- SDST N/A
- Revenue Next Year
- ECOR $44.35
- SDST N/A
- P/E Ratio
- ECOR N/A
- SDST N/A
- Revenue Growth
- ECOR 30.16
- SDST N/A
- 52 Week Low
- ECOR $4.16
- SDST $0.14
- 52 Week High
- ECOR $19.49
- SDST $12.56
- Technical
- Relative Strength Index (RSI)
- ECOR 41.18
- SDST 30.49
- Support Level
- ECOR $4.74
- SDST $2.75
- Resistance Level
- ECOR $5.32
- SDST $3.33
- Average True Range (ATR)
- ECOR 0.34
- SDST 0.29
- MACD
- ECOR 0.00
- SDST -0.13
- Stochastic Oscillator
- ECOR 22.22
- SDST 20.45
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).